The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) is strictly essential for viral replication and it has been used as viral target for anti-HCV drug development. All small molecules which have been identified to be selective non-nucleoside inhibitors (NNI) of the HCV RdRp to date are reported.
No takes yet. Share an insight, caveat, or question.
Enzo Tramontano (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: